Incekaralar Tibbi Cihazlar Tic
⚠️ Moderate Risk
FEI: 3009438934 • Ankata • TURKEY
FEI Number
3009438934
Location
Ankata
Country
TURKEYAddress
No 16 N Akar Mah Balgat, , Ankata, , Turkey
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
Frequently Asked Questions
What is Incekaralar Tibbi Cihazlar Tic's FDA import refusal history?
Incekaralar Tibbi Cihazlar Tic (FEI: 3009438934) has 2 FDA import refusal record(s) in our database, spanning from 12/21/2012 to 12/21/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Incekaralar Tibbi Cihazlar Tic's FEI number is 3009438934.
What types of violations has Incekaralar Tibbi Cihazlar Tic received?
Incekaralar Tibbi Cihazlar Tic has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Incekaralar Tibbi Cihazlar Tic come from?
All FDA import refusal data for Incekaralar Tibbi Cihazlar Tic is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.